Next Article in Journal
Grip Strength, Anthropometric Indices, and Their Combination in Screening for Metabolic Syndrome in the Korean Population
Previous Article in Journal
Performance of the Mammoth Balloon Catheter in Patients with Severe Aortic Valve Stenosis Undergoing Percutaneous Treatment
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Pre-Transplant Dual-Energy X-ray Absorptiometry (DXA)-Derived Body Composition Measures as Predictors of Treatment Outcomes and Early Post-Transplant Complications in Patients with Multiple Myeloma (MM) Treated with Autologous Hematopoietic Stem Cell Transplantation (AutoHSCT)

by
Paula Jabłonowska-Babij
1,*,
Diana Jędrzejuk
2,
Maciej Majcherek
1,
Agnieszka Szeremet
1,
Magdalena Karasek
1,
Bartłomiej Kuszczak
1,
Krzysztof Kujawa
3,
Milena Sitkiewicz
1,
Marcin Landwójtowicz
2,
Tomasz Wróbel
1,
Maciej Tomasiewicz
1 and
Anna Czyż
1
1
Department and Clinic of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, 50-367 Wroclaw, Poland
2
Department and Clinic of Endocrinology, Diabetology, and Isotope Therapy, Wroclaw Medical University, 50-367 Wroclaw, Poland
3
Statistical Analysis Centre, Wroclaw Medical University, 50-367 Wroclaw, Poland
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(19), 5987; https://doi.org/10.3390/jcm13195987
Submission received: 20 August 2024 / Revised: 22 September 2024 / Accepted: 3 October 2024 / Published: 8 October 2024
(This article belongs to the Section Hematology)

Abstract

Background/Objectives: Changes in muscle mass and bone density are common in multiple myeloma (MM) patients. Dual-energy X-ray absorptiometry (DXA) offers precise, non-invasive insights into a patient’s physical condition before autologous stem cell transplantation (autoHSCT). This study examines how pre-transplant body composition impacts treatment outcomes and early complications in MM patients undergoing autoHSCT. Methods: This study is a single-center, retrospective analysis of patients with MM who were treated with first or second autoHSCT and underwent DXA pre-transplant between 11 August 2019 and 12 June 2024. Results: We conducted a study of pre-transplant body composition in 127 patients with MM. Among them, 108 (85%) qualified for first autoHSCT, while 19 (15%) qualified for a second. The median age of the patients was 64 years (range 50–73). In the Cox proportional hazards regression conducted in the group of women, Total Body %Fat was a statistically significant predictor for progression-free survival (PFS) (HR = 0.07, 95% CI = 0.01,0.6, p = 0.0157). In the Mann–Whitney U test conducted on males, Lean Mass/Height2 and Appen. Lean Height2 were statistically significant predictors of early infections after autoHSCT (Z = 1.98, p = 0.0473 and Z = 2.32, p = 0.0204, respectively). In males, Fat Mass/Height2 was a significant predictor of non-infectious toxicity related to treatment (Z = −1.98, p = 0.0476). Conclusions: In women, higher levels of adipose tissue initially appear to exert a protective effect; however, this benefit diminishes over time, with greater fat mass eventually correlating with an increased risk of disease progression. In men, muscle mass has been identified as a significant predictor of early infection risk post-autoHSCT. Furthermore, our findings indicate that an increased amount of adipose tissue in men is statistically associated with a higher risk of non-infectious treatment-related toxicity. These conclusions highlight the critical need for further investigation into the role of body composition.
Keywords: body composition; multiple myeloma; autologous hematopoietic stem cell transplantation; progression-free survival; infections body composition; multiple myeloma; autologous hematopoietic stem cell transplantation; progression-free survival; infections

Share and Cite

MDPI and ACS Style

Jabłonowska-Babij, P.; Jędrzejuk, D.; Majcherek, M.; Szeremet, A.; Karasek, M.; Kuszczak, B.; Kujawa, K.; Sitkiewicz, M.; Landwójtowicz, M.; Wróbel, T.; et al. Pre-Transplant Dual-Energy X-ray Absorptiometry (DXA)-Derived Body Composition Measures as Predictors of Treatment Outcomes and Early Post-Transplant Complications in Patients with Multiple Myeloma (MM) Treated with Autologous Hematopoietic Stem Cell Transplantation (AutoHSCT). J. Clin. Med. 2024, 13, 5987. https://doi.org/10.3390/jcm13195987

AMA Style

Jabłonowska-Babij P, Jędrzejuk D, Majcherek M, Szeremet A, Karasek M, Kuszczak B, Kujawa K, Sitkiewicz M, Landwójtowicz M, Wróbel T, et al. Pre-Transplant Dual-Energy X-ray Absorptiometry (DXA)-Derived Body Composition Measures as Predictors of Treatment Outcomes and Early Post-Transplant Complications in Patients with Multiple Myeloma (MM) Treated with Autologous Hematopoietic Stem Cell Transplantation (AutoHSCT). Journal of Clinical Medicine. 2024; 13(19):5987. https://doi.org/10.3390/jcm13195987

Chicago/Turabian Style

Jabłonowska-Babij, Paula, Diana Jędrzejuk, Maciej Majcherek, Agnieszka Szeremet, Magdalena Karasek, Bartłomiej Kuszczak, Krzysztof Kujawa, Milena Sitkiewicz, Marcin Landwójtowicz, Tomasz Wróbel, and et al. 2024. "Pre-Transplant Dual-Energy X-ray Absorptiometry (DXA)-Derived Body Composition Measures as Predictors of Treatment Outcomes and Early Post-Transplant Complications in Patients with Multiple Myeloma (MM) Treated with Autologous Hematopoietic Stem Cell Transplantation (AutoHSCT)" Journal of Clinical Medicine 13, no. 19: 5987. https://doi.org/10.3390/jcm13195987

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop